Literature DB >> 18231758

The expression of TNF-alpha and ICAM-1 in lesions of lichen planus and its implication.

Xu'e Chen1, Zhixiang Liu, Qing Yue.   

Abstract

In order to investigate the role of TNF-and ICAM-1 in the pathogenesis of lichen planus, immunohistochemistry was used to detect the expression of TNF-and ICAM-1 in skin lesions of the patients with lichen planus and skin tissues of normal subjects. The results showed that positive rates of TNF-alpha and ICAM-1 expressions in lichen planus were significantly higher than those in normal skins (both P<0.05). Meanwhile, there was a obvious correlation between the increase of TNF-alpha and that of ICAM-1 in lichen planus. The expression of TNF-alpha and ICAM-1 might play an important role in the development of lichen planus.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18231758     DOI： 10.1007/s11596-007-0632-x

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN： 1672-0733


  7 in total

1.  TNF-alpha expression and apoptosis-regulating proteins in oral lichen planus: a comparative immunohistochemical evaluation.

Authors:  A Sklavounou; E Chrysomali; A Scorilas; A Karameris
Journal:  J Oral Pathol Med       Date:  2000-09       Impact factor: 4.253

2.  Oral lichen planus: immunohistology of mucosal lesions.

Authors:  Mariana Villarroel Dorrego; María Correnti; Rafael Delgado; Felix J Tapia
Journal:  J Oral Pathol Med       Date:  2002-08       Impact factor: 4.253

3.  Cell proliferation activity and the expression of cell cycle regulatory proteins in oral lichen planus.

Authors:  Makoto Hirota; Takaaki Ito; Koji Okudela; Ryoichi Kawabe; Takuya Yazawa; Hiroyuki Hayashi; Yukio Nakatani; Kiyohide Fujita; Hitoshi Kitamura
Journal:  J Oral Pathol Med       Date:  2002-04       Impact factor: 4.253

4.  Overexpression of tumour necrosis factor-alpha-converting enzyme in psoriasis.

Authors:  M Kawaguchi; Y Mitsuhashi; S Kondo
Journal:  Br J Dermatol       Date:  2005-05       Impact factor: 9.302

5.  Expression of TNF-alpha in oral lichen planus treated with fluocinolone acetonide 0.1%.

Authors:  Kobkan Thongprasom; Kittipong Dhanuthai; Wilairat Sarideechaigul; Ponlatham Chaiyarit; Mantharop Chaimusig
Journal:  J Oral Pathol Med       Date:  2006-03       Impact factor: 4.253

6.  The role of perforin-mediated apoptosis in lichen planus lesions.

Authors:  Marija Kastelan; Larisa Prpić Massari; Franjo Gruber; Gordana Zamolo; Gordana Zauhar; Miran Coklo; Danijel Rukavina
Journal:  Arch Dermatol Res       Date:  2004-09-28       Impact factor: 3.017

7.  Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-alpha and their degranulation is associated with expression of ICAM-1 in the epidermis.

Authors:  L Ackermann; I T Harvima
Journal:  Arch Dermatol Res       Date:  1998-07       Impact factor: 3.017
  7 in total
  5 in total

1.  Expression of apoptosis related protein in skin lesions of lichen planus and its implication.

Authors:  Xu'e Chen; Yan Wu; Jiawen Li; Zhixiang Liu; Qing Yue; Houjun Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-06-19

2.  Degranulated mast cells and TNF-α in oral lichen planus and oral lichenoid reactions diseases.

Authors:  Parichehr Ghalayani; Gholamreza Jahanshahi; Zahra Saberi
Journal:  Adv Biomed Res       Date:  2012-08-28

3.  The prevalence of hepatitis C Virus (HCV) among lichen planus patients and its clinical pattern at the University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria.

Authors:  Agwu Bob Ukonu; Uhunmwangho Augustine
Journal:  Glob J Health Sci       Date:  2012-08-05

4.  Assessment of systemic inflammation with neutrophil-lymphocyte ratio in lichen planus.

Authors:  Hatice Ataş; Bengü Çevirgen Cemil; Gökçe Işıl Kurmuş; Müzeyyen Gönül
Journal:  Postepy Dermatol Alergol       Date:  2016-06-17       Impact factor: 1.837

5.  The Measurement of Serum Tumor Necrosis Factor-alpha Levels in Patients with Lichen Planus.

Authors:  Yesim Akpinar Kara
Journal:  Indian J Dermatol       Date:  2018 Jul-Aug       Impact factor: 1.494
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.